SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000898432-07-000502
Filing Date
2007-06-25
Accepted
2007-06-25 13:50:54
Documents
2
Group Members
BIOTECHNOLOGY VALUE FUND II, L.P.BIOTECHNOLOGY VALUE FUND, L.P.BVF INC.BVF INVESTMENTS, L.L.C.BVF PARTNERS, L.P.INVESTMENT 10, L.L.C.

Document Format Files

Seq Description Document Type Size
1 bvf-arqule_13g.htm SC 13G 94649
2 EXHIBIT 1 exhibit_99.htm EX-99 12941
  Complete submission text file 0000898432-07-000502.txt   109818
Mailing Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
Business Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606 415-288-23
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6282 Investment Advice

Mailing Address 19 PRESIDENTIAL WAY WOBURN MA 01801
Business Address 19 PRESIDENTIAL WAY WOBURN MA 01801 781-994-0300
ARQULE INC (Subject) CIK: 0001019695 (see all company filings)

IRS No.: 043221586 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-48819 | Film No.: 07938402
SIC: 2834 Pharmaceutical Preparations